OpenLegislation

Part I COMMUNITY METHODS OF ANALYSIS

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Column (1)Column (2)
SubstanceCommunity provision
AmproliumPart 1 of Annex II to Directive 74/203/EECf1 as corrected by a corrigendum published on 1st May 1974f2
AvoparcinPart 1 of the Annex to Directive 81/715/EECf3
CarbadoxPart C of the Annex to Directive 1999/27/ECf4
CopperPart 3 of the Annex to Directive 78/633/EECf5
DiclazurilPart B of the Annex to Directive 1999/27/EC(d)
Dinitolmide (DOT)Part 3 of Annex II to Directive 74/203/EEC(a)
EthopabatePart 2 of Annex II to Directive 74/203/EEC(a)
FlavophospholipolPart 2 of the Annex to Directive 78/633/EEC(e)
HalofuginoneThe Annex to Directive 93/70/EECf6
Menadione (vitamin K3)Part 5 of Annex II to Directive 74/203/EEC(a)
Methyl benzoquatePart 2 of the Annex to Directive 93/117/ECf7
Monensin sodiumPart 2 of the Annex to Directive 81/715/EEC(c)
NicarbazinPart 4 of Annex II to Directive 74/203/EEC(a)
OlaquindoxPart C of the Annex to Directive 98/64/ECf8
RobenidinePart 1 of the Annex to Directive 93/117/EC(g)
SpiramycinThe Annex to Directive 84/425/EECf9
TylosinPart 4 of Annex II to Directive 72/199/EECf10
VirginiamycinPart 5 of Annex II of Directive 72/199/EEC(j) as replaced by Article 2 of, and Annex II to, Directive 84/4/EECf11
Vitamin APart 1 of Annex II to Directive 73/46/ECf12
Zinc bacitracinPart 1 of the Annex to Directive 78/633/EEC(e) as replaced by Article 3 of, and Annex III to, Directive 84/4/EEC(k)

Annotations

Footnotes

f1

OJ No. L108, 22.4.74, p. 7.

f2

OJ No. L121, 3.5.74, p. 56.

f3

OJ No. L257, 10.9.81, p. 38.

f4

OJ No. L118, 6.5.99, p. 36.

f5

OJ No. L206, 29.7.78, p. 43.

f6

OJ No. L234, 17.9.93, p. 17.

f7

OJ No. L329, 30.12.93, p. 54.

f8

OJ No. L257, 19.9.98, p. 14.

f9

OJ No. L238, 6.9.84, p. 34.

f10

OJ No. L123, 29.5.72, p. 6 (OJ/SE 1966—72, p. 74).

f11

OJ No. L15, 18.1.84, p. 28.

f12

OJ No. L83, 30.3.73, p. 21.